Black gynecologic oncology patients with COVID-19 are more likely to require hospitalization and have a disproportionate rate of death, according to a study published in Cancer. Investigators abstracted data from gynecologic oncology patients with COVID-19 infection among eight New York City area hospital systems. COVID-19-related hospitalization and mortality were analyzed using a multivariable mixed-effects logistic regression model. Overall, 34.7% and 65.3% of the 193 patients who had gynecologic cancer and COVID-19 were black and non-black, respectively. The researchers found that compared with non-blacks, black patients were more likely to require hospitalization (71.6% vs 46.0%). Overall, 41.2% of the 34 patients who died from COVID-19 were black. Among those who were hospitalized, black patients were significantly more likely than non-black patients to have three or more comorbidities (81.1% vs 59.2%); to reside in Brooklyn (81.0% vs 44.4%); to live with family (69.4% vs 41.6%); and to have public insurance (79.6% vs 53.4%). Among those younger than 65, black patients were more likely to need hospitalization compared with non-black patients in a multivariable analysis (odds ratio, 4.87). “COVID-19 infection outcomes experienced by black women highlight preexisting disparities and call for multifaceted attention to address these longstanding differences in health outcomes among patients with gynecologic cancer,” the authors write.

For latest news and updates